Using Anterior Thoracic Perforating Artery for Head and Neck Surgery
Anterior Thoracic Perforating Artery (PATA); Systematization and Applications in Reconstructive Surgery of the Head and Neck
This study is testing if using a specific artery can help improve surgery for patients with head and neck cancer by making it easier to reconstruct the area while keeping important functions like swallowing and speaking.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ramsay Générale de Santé Academic / other |
| Locations | 1 site (Lyon) |
| Trial ID | NCT06140160 on ClinicalTrials.gov |
What this trial studies
This study explores the use of the anterior thoracic perforating artery (PATA) in reconstructive surgery for patients with cancers of the upper aero-intestinal tract. It focuses on the application of cutaneous and fasciocutaneous flaps to facilitate reconstruction while preserving essential functions such as swallowing and phonation. The study involves the use of Doppler ultrasound to assess the vascular anatomy and suitability of the flaps for surgical procedures. By optimizing flap selection, the study aims to improve surgical outcomes in head and neck cancer patients.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who require Doppler ultrasound for the supra-aortic trunks and are undergoing reconstructive surgery for upper aero-intestinal tract cancer.
Not a fit: Patients with a history of cervical surgery or those with anatomical limitations that prevent access to the lower lateral cervical region may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance reconstructive options and functional recovery for patients undergoing surgery for upper aero-intestinal tract cancers.
How similar studies have performed: While the use of various flaps in reconstructive surgery is established, the specific application of the anterior thoracic perforating artery in this context is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient, man or woman over 18 years old, * Patient admitted for an indication for Doppler ultrasound of the supra-aortic trunks (previously prescribed for any medical reason), * Patient having received written information and collection of the non-opposition of the patient to participate in the study, * Patient affiliated or beneficiary of a security regime social. Exclusion Criteria: * Minor patient, * History of cervical surgery, * Patients who have an inaccessible morphology to an exploration of the lower lateral cervical region, high, below and above the right and left clavicle such as the small necks, and/or with dermato-sclerosis, * Patients who do not have the intellectual or physical allowing them to give their consent, * Patient in period of exclusion due to another research still in progress at the time of inclusion, * Refusal to participate in the patient's study, * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial decision or administrative, * Pregnant, breastfeeding or parturient woman, * Patient hospitalized without consent.
Where this trial is running
Lyon
- Hôpital Privé Jean Mermoz — Lyon, France (Recruiting)
Study contacts
- Study coordinator: Jean-François Oudet
- Email: jf.oudet@ecten.eu
- Phone: 0683346567
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.